Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlanta, GA
NCT07039591 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-09-05
Summary
A randomized open label crossover trial to assess performance attributes and acceptability of non-medicated intravaginal rings among sexually active women in Atlanta, GA
Conditions
- Contraceptive Usage
Interventions
- DEVICE
-
Pro-type IVR
Women will test three non-medicated IVRs on two one-day clinic visits (two on the first day, one on the second day) by manipulating them, vaginally inserting each ring and then performing a controlled set of tasks simulating routine daily activities with the ring in the vagina.
Sponsors & Collaborators
-
Emory University
collaborator OTHER -
Population Council
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 49 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-08-08
- Primary Completion
- 2026-04-30
- Completion
- 2026-10-30
Countries
- United States
Study Locations
More Related Trials
-
Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring
NCT02920827 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya
NCT02529683 ·Status: COMPLETED ·Phase: NA
-
Safety and Acceptability Study of a Placebo Antibody-Based Nonhormonal Contraceptive Intravaginal Ring
NCT06740253 ·Status: COMPLETED ·Phase: NA
-
Safety and Acceptability of Vaginal Rings That Protect Women From Unintended Pregnancy
NCT01796613 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of VR101 as a Personal Lubricant
NCT04288752 ·Status: COMPLETED ·Phase: NA
-
A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery Method
NCT00469170 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis
NCT02314429 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women
NCT02010593 ·Status: COMPLETED ·Phase: PHASE2
-
Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring
NCT03762382 ·Status: UNKNOWN ·Phase: PHASE2
-
Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness
NCT02029053 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)
NCT00700284 ·Status: COMPLETED ·Phase: PHASE1
-
Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness
NCT03150407 ·Status: COMPLETED ·Phase: NA
-
Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium
NCT00332995 ·Status: COMPLETED ·Phase: PHASE1
-
Timing of Pessary Care
NCT02371083 ·Status: COMPLETED ·Phase: NA
-
Condom Performance in a Longitudinal Enhanced Assessment of User Experiences
NCT02753842 ·Status: COMPLETED ·Phase: NA
-
Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women
NCT01617096 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Dapivirine Vaginal Ring (VR) in Adolescents
NCT02028338 ·Status: COMPLETED ·Phase: PHASE2
-
To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women
NCT02862171 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing the Disintegration, Safety, and Acceptability of Placebo Vaginal Inserts for the Delivery of Vaginal Products
NCT02534779 ·Status: COMPLETED ·Phase: NA
-
PK Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel
NCT03467347 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter, Open-Label, Non-Comparative Study of the Safety and Contraceptive Efficacy of the Woman's Condom
NCT01223313 ·Status: COMPLETED ·Phase: NA
-
Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms
NCT02569697 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (TDF IVR-002)
NCT02762617 ·Status: TERMINATED ·Phase: PHASE1
-
Women's Input on Sexual Health
NCT02057419 ·Status: COMPLETED
-
PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel
NCT02855346 ·Status: COMPLETED ·Phase: PHASE1